Silverleafe Capital Partners’s Clover Health Investments CLOV Stock Holding History

Silverleafe Capital Partners’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$210K	Hold	40,000	–	–	0.06%	98
2026 Q1	$70.4K	Hold	40,000	–	–	0.02%	103
2025 Q4	$94K	Sell	40,000 -5,000	-11%	-$13.7K	0.03%	98
2025 Q3	$138K	Hold	45,000	–	–	0.04%	92
2025 Q2	$126K	Hold	45,000	–	–	0.04%	87
2025 Q1	$162K	Hold	45,000	–	–	0.06%	86
2024 Q4	$142K	Buy	45,000 +29,091	+183%	+$104K	0.05%	99
2024 Q3	$44.9K	Buy	+15,909	New	+$36.4K	0.02%	80

Other funds holding CLOV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Silverleafe Capital Partners's CLOV Position: Q2 2026 in Review

Silverleafe Capital Partners held its Clover Health Investments (CLOV) position steady in Q2 2026 at 40,000 shares worth $210K. The position accounts for 0.06% of the portfolio, ranked #98.

Silverleafe Capital Partners first reported a position in CLOV in Q3 2024 and has held it in 8 quarters since. 226 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

Silverleafe Capital Partners held 40,000 shares of Clover Health Investments worth $210K as of Q2 2026.
Silverleafe Capital Partners left its Clover Health Investments share count unchanged in Q2 2026.
Clover Health Investments made up 0.06% of Silverleafe Capital Partners's portfolio in Q2 2026, its #98 holding.
Silverleafe Capital Partners first reported a position in Clover Health Investments in Q3 2024 and has held it in 8 quarters since.
226 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Silverleafe Capital Partners's 13F filing for Q2 2026, filed 2 Jul 2026.